Operating Lease, Right-of-Use Asset of Poseida Therapeutics, Inc. from 30 Jun 2020 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Poseida Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2020 to 30 Sep 2024.
  • Poseida Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2024 was $19,054,000, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Poseida Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $19,054,000 -$3,517,000 -16% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $19,962,000 -$3,434,000 -15% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 $20,855,000 -$3,353,000 -14% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $21,726,000 -$3,359,000 -13% 31 Dec 2023 10-Q 07 Nov 2024 2024 Q3
Q3 2023 $22,571,000 -$4,429,000 -16% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $23,396,000 -$4,585,000 -16% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $24,208,000 -$4,739,000 -16% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $25,085,000 -$1,092,000 -4.2% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $27,000,000 +$1,813,000 +7.2% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $27,981,000 +$1,912,000 +7.3% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $28,947,000 +$2,008,000 +7.5% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $26,177,000 +$1,191,000 +4.8% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $25,187,000 +$117,000 +0.47% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $26,069,000 +$5,924,000 +29% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $26,939,000 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $24,986,000 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $25,070,000 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $20,145,000 30 Jun 2020 10-Q 20 Aug 2020 2020 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.